SCHEMBL535052

SCHEMBL535052

CCCc1c[nH]c(-c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.44
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
CTSK P43235 1/20 0.43
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 3/20 0.40
HPGD P15428 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 2/20 0.40
ADORA3 P0DMS8 4/20 0.39
ADORA2A P29274 4/20 0.39
ADORA1 P30542 3/20 0.39
PIN1 Q13526 2/20 0.39
TSHR P16473 1/20 0.39
POLB P06746 1/20 0.39
SREBF2 Q12772 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27843948 0.90 KCNH2 (0.41) PDE5APDE3BPDE3ANPC1RAB9A
SCHEMBL3005573 0.88 KCNH2 (0.47) PDE5APDE3BPDE3ASMN1; SMN2TP53
SCHEMBL2780530 0.87 POLB (0.41) PDE5APDE3BPDE3AKDM4EALDH1A1
SCHEMBL29629123 0.87 KCNH2 (0.50) SMN1; SMN2TP53ADORA3ADORA2AMAPT
SCHEMBL8973267 0.87 KCNH2 (0.50) SMN1; SMN2TP53ADORA3ADORA2AMAPT
SCHEMBL27724619 0.87 KCNH2 (0.50) SMN1; SMN2TP53ADORA3ADORA2AMAPT
SCHEMBL30670275 0.85 MTOR (0.38) PDE5APDE3BPDE3AKDM4EALDH1A1
SCHEMBL24088760 0.83 NPC1 (0.45) CTSKKDM4EHPGDNPC1RAB9A
SCHEMBL13115362 0.83 NPC1 (0.42) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL1436268 0.82 LOXL2 (0.40) CTSKKDM4EALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108554456-A A kind of application of rare earth imidazole salt compound as catalyst 苏州大学 2018-09-21 CN disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
EP-1952918-B1 METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM TOYO INK MFG CO (JP) 2013-05-22 EP disclosed
US-8440110-B2 Method for producing metal particle dispersion, conductive ink using metal particle dispersion produced by such method, and conductive coating film TOYO INK MFG CO., LTD. (JP) 2013-05-14 US disclosed
CN-101287566-B Method for producing metal microparticle dispersion, conductive ink using metal microparticle dispersion produced by the method, and conductive coating film TOYO INK MFG CO 2012-05-23 CN disclosed
EP-1990377-B1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION CONTAINING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KK (JP) 2012-02-08 EP disclosed
CN-101384674-B Colored metallic pigment, process for producing the same, and coating composition and cosmetic preparation comprising said colored metallic pigment TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2011-12-28 CN disclosed
US-7998266-B2 Colored metallic pigment, process for producing the same, and coating composition and cosmetic preparation containing said colored metallic pigment TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2011-08-16 US disclosed
US-20110175040-A1 METHOD FOR PRODUCING METAL PARTICLE DISPRESION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM TOYO INK MFG CO., LTD. (JP) 2011-07-21 US disclosed
US-7981327-B2 Method for producing metal particle dispersion, conductive ink using metal particle dispersion produced by such method, and conductive coating film TOYO INK MFG. CO. LTD. (JP) 2011-07-19 US disclosed
US-20090017082-A1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION CONTAINING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2009-01-15 US disclosed
EP-1990377-A1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION COMPRISING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2008-11-12 EP disclosed
CN-101287566-A Method for producing metal microparticle dispersion, conductive ink using metal microparticle dispersion produced by the method, and conductive coating film TOYO INK MFG CO (JP) 2008-10-15 CN disclosed
EP-1952918-A1 METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM Toyo Ink Mfg. Co., Ltd (JP) 2008-08-06 EP disclosed
US-20080146569-A1 Nicotinamide Derivatives PFIZER INC. 2008-06-19 US disclosed
US-6492377-B1 Imidazotriazolopyrimidines with adenosine-antagonistic activity BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-12-10 US disclosed
EP-0585014-B1 Process for the preparation of 2-(un)substituted 4-alkylimidazoles SHIONOGI & CO (JP) 2000-02-23 EP disclosed
CN-1091130-A The preparation of imidazoles SHIONOGI & CO (JP) 1994-08-24 CN disclosed
US-5312927-A Preparation of imidazoles SHIONOGI & CO., INC. (JP) 1994-05-17 US disclosed
EP-0585014-A2 Process for the preparation of 2,5-disubstituted imidazoles SHIONOGI & CO., LTD. (JP) 1994-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 PDE5A 3337/4885PDE3B 3866/4885PDE3A 3801/4885
US-20080146569-A1 Nicotinamide Derivatives NNT, NAMPT, NADK PDE5A 404/4885PDE3B 359/4885PDE3A 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.